Get In Touch

There is little contention about the importance of asthma spacers for people suffering from various degrees of the pulmonary disease. The direct relationship between proper breathing and healthy lungs has compelled medical practitioners and researchers to invest time and resources in treating pulmonary diseases. The permanent need for asthma spacers in critically ill patients has created increased demand within the global market.

  • Over the past decade, changing propensities and lifestyles of the masses have led to an increase in the incidence of asthma and other lung disorders. In addition to this, medical researchers have witnessed a decline in the immunity levels of the masses over the past few years. Considering the factors stated above, the demand within the global asthma spacers market is projected to rise in the years to follow.
  • The National Asthma Council, Australia has released crucial information related to the use of asthma spacers. The council describes the shape and specifications of an ideal asthma spacer. Moreover, the ease of using these spacers has also been enunciated by the council. COPD or asthma medication can be easily administered with the help of these spacers. A metered dose inhaler is often attached with these spacers in order to ease inhalation. The total demand for these spacers has increased by a dramatic chase in recent times.

Spacers help in coordinating the processes of pressing the puffer and breathing in. This is also an important factor responsible for the growth of the global asthma spacers market. Over the course of the next decade, several new technologies are expected to make way into the medical industry. Moreover, investments in development of high-end spacers and technologies have also gained prominence in recent times. The revenue index of the global asthma spacers market is expected to improve in the years to follow.

Asthma Spacers Market - Snapshot

Asthma is a chronic respiratory condition that affects millions of people around the world. Aerosol drug delivery is the first line administration route in asthma management, and metered dose inhalers (MDIs) are the most common type of inhalers used in asthmatic conditions. However, poor inhalation techniques have led to poor control of asthma. Valve holding chambers/spacers are designed to counter the problem. A spacer, usually attached with an MDI, is an external device that provides better drug delivery by increasing inhalation and actuation. The global asthma spacers market was valued at US$ 1,330.56 Mn in 2017. It is expected to expand at a CAGR of 3.7% from 2018 to 2026.

asthma spacers market

Spacers with metered dose inhalers are used to treat several respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Technological advancements in spacer devices is likely to propel the market in the near future.

The global asthma spacers market can be segmented based on product type, distribution channel, and geography. In terms of product type, the market can be divided into aerochamber, optichamber, volumatic, inspirease, and others. The aerochamber segment is likely to account for a leading share of the global market during the forecast period, owing to the wide adoption of these devices for the management of asthma. Technological developments in aerochambers are estimated to boost the segment during the forecast period. Based on distribution channel, the asthma spacers market can be classified into retail pharmacy, hospital pharmacy, and e-commerce. The retail pharmacy segment is expected to hold a significant share of the global asthma spacers market, due to a rise in over-the-counter sales of asthma spacers with metered dose inhalers.

In terms of geography, the global asthma spacers market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe accounted for a major share of the global market in 2017. High prevalence of asthma, favorable reimbursement policies, and increase in government initiatives that mandate the use of asthma spacers with metered dose inhalers are driving demand for asthma spacers in these regions. The asthma spacers market in Asia Pacific is likely to expand at a significant CAGR during the forecast period. A large asthmatic population with poorly controlled symptoms and rise in health care expenditure are projected to fuel the market in the region in the coming years. Moreover, low cost of manufacturing in China and India has resulted in a rise in the number of production facilities in the countries, attracting key players to the region from across the world.

Key players operating in the global asthma spacers market include Trudell Medical Internationa, Pari Gmbh, GlaxoSmihKline plc, Medical Development International, Cipla, Lupin, Clement Clarke, AstraZeneca, Merck & Co., and Fisons. These companies have established themselves in the market and enjoy brand loyalty among customers. They have a diverse product offering and an extensive distribution system across the world. Also, entry of small players is high, especially in emerging regions of the market such as Asia. However, high quality standards set by market leaders are anticipated to restrain the penetration of new entrants in the market.

Growing Clinical Acceptance of Inhaled Therapies Boosts Asthma Spacers Market

The drive for asthma spaces market stems from the widespread acceptance of pressurized metered-dose inhaler (MDI) in the pharmacological management of asthma. The benefit/risk ratio and tolerability are the key attributes propelling the popularity of use of MDI, which, in turn is propelling the prospects in the asthma spacers market. The concerns of the incorrect usage of MDI have been at the forefront in driving the evolution of the asthma spacers market. Growing number of patients with COPD and asthma who need critical care is a key trend bolstering the clinical need for spacer technologies. The asthma spacers market has also benefitted from the advancements made in mechanism of valved holding chambers. Most commonly, aerosol drug delivery is used in MDI using asthma spacers. Over the past few years, the asthma spacers market has been witnessing new growth avenues due to the increased focus on reducing the side-effects of asthma drugs. A case in point is reducing the impact of corticosteroids, since they lead to oral candidiasis.

In the times when coronavirus disease 2019 (COVID-19) has led to severe health pandemic, valved-holding chambers (VHCs). Thus, though the pandemic-led lockdowns have crippled economies and healthcare systems, there also has been surge in demand for medical devices, equipment, and consumables that are used in the management of the symptoms. The high transmissibility of the virus provides a robust ground for the adoption of asthma spacers. Many countries have stressed on discontinuation of small-volume nebulizers (SVNs) and adopt asthma spacers. However, in some countries where healthcare systems are quite costly for a large percentage of population, reimbursement plays a crucial factor in decision-making. On the other hand, researchers are accumulating evidence on the role of asthma spacers on decreasing early readmission. The presence of a large percentage of asymptomatic COVID-19 patients has also made it necessary for patients to embrace asthma spacers, thereby favoring the opportunity in the asthma spacers market.

Global Asthma Spacers Market: Overview

This report analyzes the current and future scenario of the global asthma spacers market. Rise in geriatric population, high prevalence of asthma, and increase in patient preference for the MDI/spacer combination are the major drivers of the global market.

The global asthma spacers market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to segments based on product type, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises a competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by region, and market share analysis, by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global asthma spacers market.

Global Asthma Spacers Market: Key Segments

The global asthma spacers market has been segmented based on product type, distribution channel, and region. In terms of product type, the global market has been divided into aerochamber, optichamber, volumatic, inspirease, and others. The aerochamber segment is likely to account for a leading share of the global asthma spacers market during the forecast period, owing to wide adoption of aerochambers for the management of asthma. Technological developments in aerochamber are projected to boost the segment during the forecast period. Based on distribution channel, the global market has been classified into retail pharmacy, hospital pharmacy, and e-commerce. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Asthma Spacers Market: Regional Outlook

In terms of region, the global asthma spacers market has been segmented into five major regions and key countries/sub-regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (Saudi Arabia, Israel, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global asthma spacers market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key players in the global asthma spacers market are Koninklijke Philips N.V, Trudell Medical International, Medical Development International, Merck & Co., Pari Gmbh, AstraZeneca, and GlaxoSmithKline plc.

The global asthma spacers market has been segmented as below:

Product Type

  • Aerochamber
  • Optichamber
  • Volumatic
  • Inspirease
  • Others

Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • E-commerce

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • Saudi Arabia
    • Israel
    • Rest of Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Asthma Spacers Market